Rahul D. Ballal

Director · 2 filings · Latest: Jun 18, 2026

AGIOS PHARMACEUTICALS, INC.

Enliven Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
AGIO	Rahul D. Ballal	Director	Jun 18, 2026	Option Exercise	$0.00	2,816	—	15,230	Jun 23 9:25 PM
AGIO	RAHUL BALLAL	—	Nov 7, 2024	Proposed Sale	$53.52	10,000	$535.2K	—	Nov 7 9:51 PM
ELVN	Ballal Rahul D.	—	Oct 8, 2024	Proposed Sale	$27.45	10,420	$286.0K	—	Oct 8 7:59 PM